Page last updated: 2024-08-24

imiquimod and Recrudescence

imiquimod has been researched along with Recrudescence in 71 studies

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-19902 (2.82)18.7374
1990's9 (12.68)18.2507
2000's35 (49.30)29.6817
2010's21 (29.58)24.3611
2020's4 (5.63)2.80

Authors

AuthorsStudies
Aromataris, EC; Greenwood, JE; Klotz, T; Munn, Z1
Baker, C; MacMahon, B; Sinclair, R; Spelman, L; Supranowicz, M1
Chen, Y; Dai, Z; Han, L; Huang, RY; Liang, CL; Liu, H; Lu, C; Qiu, F; Yan, Y; Zhang, Q1
Enomoto, T; Nishijima, K; Sugai, S1
DeAngelis, F; Greenwald, Z; Rampakakis, E; Rodier, C; Steben, M; Stutz, M; Thomas, R1
Cavezza, S; Liu, X; Mounsey, K; Ni, G; Pan, X; Wang, T; Yuan, J1
Clotet, B; García-Cuyás, F; Ornelas, A; Piñol, M; Revollo, B; Sirera, G; Vela, S; Videla, S1
Guevara-Gutiérrez, E; Hernández-Torres, M; Ledesma, GS; Ruiz-González, JF; Tlacuilo-Parra, A1
Bennett, K; Copas, AJ; Doré, CJ; Gilson, R; Haddow, LJ; Jit, M; Lacey, C; Meadows, J; Murray, ML; Nathan, M; Soldan, K; Tetlow, M1
Kimura, M; Oshitani, Y; Seishima, M; Tawada, C1
Goodpasture, M1
Kofler, H; Kofler, L; Nagele, U1
Bielsa Marsol, I1
Baumgartner-Nielsen, J; Lorentzen, H1
Berrios, R; Hutchens, KA; Millsop, JW; Trinh, N; Tung, R; Winterfield, L1
Goldstone, SE; Silvera, RJ; Smith, CK; Swedish, KA1
Cavicchini, S; Chimenti, S; Javor, S; Parodi, A; Patrizi, A; Pellacani, G; Rongioletti, F; Sala, R; Stingeni, L1
Cao, W; Ge, L; Li, W; Song, H; Xin, H1
Bagot, M; Battistella, M; Cavelier-Balloy, B; Duron, JB; Gorj, M; Hickman, G; Masson, V; May, P; Petit, A; Schneider, P; Vanhaecke, C; Vilmer, C1
Angel-Müller, E; Gaitán, HG; Grillo-Ardila, CF; Lethaby, A; Ruiz-Parra, AI; Salazar-Díaz, LC1
Chang, CH; Wu, CY1
Lee, NH; Roh, SG; Shin, JY; Yang, KM; Yun, SK1
Baguley, S; Delaney, E1
Ulrich, C1
Berman, B; Harrison-Balestra, C; Perez, OA; Ramirez, C; Viera, M; Villa, A; Zell, D1
Alessi, SS; Festa Neto, C; Messina, MC; Oliveira, WR; Pimentel, ER; Sanches, JA1
Armstrong, SJ; Bath-Hextall, FJ; Ozolins, M; Williams, HC1
Bai, S; Chen, MK; Liao, QM; Ma, CG; Yang, SC1
Gilardino, MS; Lee, J; Sinno, H; Tahiri, Y1
Chan, RK; Chan, YC; Ng, KY1
Conant, M; Schacker, TW; Smith, M; Stanczak, T; Thoming, C; Wang, Z1
Berman, B; Kaufman, J1
Carrasco, D; Tyring, SK; vander Straten, M1
Eul, A; Hagedorn, M; Hopfenmüller, W; Hoyme, UB; Schindler, AE; Schneede, P; Schorn, K1
Laffitte, E; Saurat, JH1
Atzori, L; Ferreli, C; Pinna, AL1
Benson, E1
Brady, S; Wilson, JD1
Cox, JT; Petry, KU; Roy, M; Rylander, E1
Benninghoff, B; Burg, G; Dummer, R; Hafner, J; Laine, E; Maier, T; Oberholzer, PA; Slade, H; Urosevic, M1
Brown, VL; Harwood, CA; Leigh, IM; McGregor, JM; Perrett, CM; Proby, CM1
Arora, SS; Bernstein, DI; Meng, TC; Schroeder, JL; Spruance, SL1
Aractingi, S; Decuypère, L; Moyse, D; Vexiau, D1
Busquets, AC; Martin-García, RF1
Ezzell, TI; Fromowitz, JS; Ramos-Caro, FA1
Martinez, V; Molina, JM; Morfin, F; Ribaud, P; Scieux, C1
Goihman-Yahr, M1
Goldenberg, G; Jorizzo, JL; Krowchuk, DP1
Neumaier, J1
Amjad, I; Chandawarkar, RY; Deckers, PJ; Piorkowski, J1
Dinehart, S; Fielder, S; Fox, TL; Jorizzo, J; Lee, JH; Ling, M; Matheson, R; McRae, S; Moore, JK1
Bernstein, DI; Harrison, CJ; Miller, RL2
Baker, D; Edwards, L; Eron, L; Ferenczy, A; Fox, TL; Hougham, AJ; Owens, ML; Schmitt, KA1
Beutner, KR; Douglas, JM; Fox, TL; Hougham, AJ; Owens, ML; Schmitt, KA; Spruance, S; Trofatter, KF; Tyring, SK1
Ahmad, SA; Ahmad, SH; Ahmadpour, OA; Syed, TA1
Edwards, L1
Maw, RD1
Christensen, B; Hengge, UR1
Allen, AL; Siegfried, EC1
Fagnani, F1
Buckley, R; Liota , E; Menon, P; Skelton, H; Smith, KJ1
Steinhorst, M1
Benninghoff, B; Christophers, E; Meyer, T; Stockfleth, E1
Aractingi, S; Aranda, C; Garland, SM; Maw, RD; Petersen, CS; Sellors, JW; Wikstrom, A1
Bernstein, DI; Harrison, CJ; Miller, RL; Tomai, MA1
Buck, HW; Fortier, M; Knudsen, J; Paavonen, J1
Berman, B1
Bernstein, DI; Harrison, CJ; Stanberry, LR1
Bernstein, DI; Harrison, CJ; Jenski, L; Voychehovski, T1
Bernstein, DI; Harrison, CJ1

Reviews

16 review(s) available for imiquimod and Recrudescence

ArticleYear
Imiquimod to prevent keloid recurrence postexcision: A systematic review and meta-analysis.
    Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2020, Volume: 28, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Dermatologic Surgical Procedures; Humans; Imiquimod; Keloid; Postoperative Care; Recurrence; Secondary Prevention

2020
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
    The Australasian journal of dermatology, 2021, Volume: 62, Issue:2

    Topics: Antineoplastic Agents; Diclofenac; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Recurrence; Skin Neoplasms

2021
Management of Condyloma Acuminata in Pregnancy: A Review.
    Sexually transmitted diseases, 2021, 06-01, Volume: 48, Issue:6

    Topics: Condylomata Acuminata; Female; Humans; Imiquimod; Papillomaviridae; Photochemotherapy; Pregnancy; Recurrence

2021
Genital warts treatment: Beyond imiquimod.
    Human vaccines & immunotherapeutics, 2018, 07-03, Volume: 14, Issue:7

    Topics: Administration, Topical; Anus Diseases; Catechin; Condylomata Acuminata; Drug Therapy, Combination; Humans; Imiquimod; Interferon Inducers; Interleukin-10; Papillomaviridae; Recurrence; Treatment Outcome

2018
Update on the classification and treatment of localized scleroderma.
    Actas dermo-sifiliograficas, 2013, Volume: 104, Issue:8

    Topics: Algorithms; Aminoquinolines; Clinical Trials as Topic; Eosinophilia; Fasciitis; Glucocorticoids; Humans; Imiquimod; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Physical Therapy Modalities; Recurrence; Scleroderma, Localized; Severity of Illness Index

2013
Imiquimod for anogenital warts in non-immunocompromised adults.
    The Cochrane database of systematic reviews, 2014, Nov-01, Issue:11

    Topics: Adult; Aminoquinolines; Anus Diseases; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Immunocompetence; Interferon Inducers; Keratolytic Agents; Male; Podophyllin; Podophyllotoxin; Randomized Controlled Trials as Topic; Recurrence; Self Administration; Warts

2014
Efficacy of 2 Representative Topical Agents to Prevent Keloid Recurrence After Surgical Excision.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2017, Volume: 75, Issue:2

    Topics: Administration, Cutaneous; Aminoquinolines; Dermatologic Agents; Humans; Imiquimod; Keloid; Mitomycin; Recurrence; Treatment Outcome

2017
[Genital warts].
    Praxis, 2009, Mar-18, Volume: 98, Issue:6

    Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Imiquimod; Keratolytic Agents; Male; Medical History Taking; Ointments; Podophyllotoxin; Recurrence; Time Factors; Treatment Outcome; Young Adult

2009
Topical treatment of field cancerization.
    Cancer treatment and research, 2009, Volume: 146

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Organ Transplantation; Photochemotherapy; Recurrence; Skin Neoplasms; Tissue Distribution

2009
Treatment options for cutaneous pyogenic granulomas: a review.
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2011, Volume: 64, Issue:9

    Topics: Aminoquinolines; Anti-Infective Agents, Local; Antineoplastic Agents; Cautery; Cryotherapy; Curettage; Granuloma, Pyogenic; Humans; Imiquimod; Laser Therapy; Recurrence; Sclerotherapy; Silver Nitrate; Skin Diseases

2011
Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
    Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4 Suppl

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Recurrence; Retrospective Studies; Time Factors

2002
Using imiquimod for genital warts in female patients.
    Journal of women's health (2002), 2004, Volume: 13, Issue:3

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Papillomaviridae; Quality of Life; Recurrence; Risk Factors; Viral Load; Vulvar Neoplasms; Women's Health

2004
Treatment of anogenital warts.
    Dermatologic clinics, 1998, Volume: 16, Issue:4

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites; Caustics; Condylomata Acuminata; Cryosurgery; Electrosurgery; Humans; Imiquimod; Immunity, Cellular; Immunologic Factors; Immunotherapy; Interferon Inducers; Keratolytic Agents; Laser Therapy; Recurrence; Treatment Failure; Treatment Outcome

1998
What's new in human papillomavirus infection.
    Current opinion in pediatrics, 2000, Volume: 12, Issue:4

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Child; Cidofovir; Cimetidine; Cytosine; Histamine H2 Antagonists; Humans; Hypnosis; Imiquimod; Keratolytic Agents; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Podophyllotoxin; Recurrence; Risk Factors; Warts

2000
[Medico-economic analysis of therapy of external condylomata acuminata].
    Annales de dermatologie et de venereologie, 2000, Volume: 127, Issue:10 Suppl

    Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Drug Evaluation; Humans; Imiquimod; Interferon Inducers; Keratolytic Agents; Laser Therapy; Podophyllotoxin; Randomized Controlled Trials as Topic; Recurrence

2000
Immunomodulation as a treatment strategy for genital herpes: review of the evidence.
    International immunopharmacology, 2002, Volume: 2, Issue:4

    Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imidazoles; Imiquimod; Recurrence

2002

Trials

14 trial(s) available for imiquimod and Recrudescence

ArticleYear
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurr
    BMC medical research methodology, 2018, 11-06, Volume: 18, Issue:1

    Topics: Adult; Drug Therapy, Combination; Female; Host-Pathogen Interactions; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Recurrence; Treatment Outcome; Vaccination

2018
Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study.
    Journal of drugs in dermatology : JDD, 2009, Volume: 8, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Double-Blind Method; Drug Administration Schedule; Humans; Imiquimod; Keloid; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Recurrence; Treatment Outcome

2009
The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.
    Trials, 2010, Apr-21, Volume: 11

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cost-Benefit Analysis; Drug Costs; Female; Genotype; Health Care Costs; Humans; Imiquimod; Male; Ointments; Patient Satisfaction; Phenotype; Polymorphism, Genetic; Prospective Studies; Recurrence; Research Design; Skin Neoplasms; Time Factors; Treatment Outcome

2010
Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10

    Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Double-Blind Method; Female; Herpes Genitalis; Humans; Imiquimod; Male; Middle Aged; Recurrence; Treatment Outcome

2002
Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
    Infectious diseases in obstetrics and gynecology, 2002, Volume: 10, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aminoquinolines; Combined Modality Therapy; Condylomata Acuminata; Female; Humans; Imiquimod; Laser Therapy; Male; Middle Aged; Patient Compliance; Patient Dropouts; Prospective Studies; Recurrence; Treatment Outcome

2002
Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
    The British journal of dermatology, 2005, Volume: 152, Issue:1

    Topics: Administration, Cutaneous; Adolescent; Adult; Aminoquinolines; Antiviral Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunocompromised Host; Interferon Inducers; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Self Administration; Treatment Outcome; Warts

2005
Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Sep-15, Volume: 41, Issue:6

    Topics: Administration, Topical; Adult; Aminoquinolines; Female; Herpes Labialis; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Pilot Projects; Recurrence; Time Factors

2005
[Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
    Annales de dermatologie et de venereologie, 2005, Volume: 132, Issue:11 Pt 1

    Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Condylomata Acuminata; Dose-Response Relationship, Drug; Female; Humans; Imiquimod; Male; Middle Aged; Recurrence; Treatment Outcome

2005
Combined immunotherapy of recalcitrant warts.
    International journal of dermatology, 2006, Volume: 45, Issue:5

    Topics: Administration, Cutaneous; Aminoquinolines; Dinitrochlorobenzene; Drug Administration Schedule; Drug Therapy, Combination; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunotherapy; Recurrence; Warts

2006
Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.
    Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:2

    Topics: Adult; Aminoquinolines; Double-Blind Method; Drug Administration Schedule; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis; Male; Ointments; Photosensitivity Disorders; Recurrence; Scalp Dermatoses; Treatment Outcome

2007
Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Archives of dermatology, 1998, Volume: 134, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Dermatitis; Double-Blind Method; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Incidence; Interferon Inducers; Male; Ointments; Pharmaceutical Vehicles; Placebos; Recurrence; Remission Induction; Safety; Self Administration; Treatment Outcome

1998
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Male; Papillomaviridae; Recurrence

1998
Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
    The Journal of dermatology, 1998, Volume: 25, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Ointments; Papillomaviridae; Papillomavirus Infections; Placebos; Recurrence; Remission Induction; Tumor Virus Infections; Vulvar Diseases

1998
Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
    International journal of STD & AIDS, 2001, Volume: 12, Issue:11

    Topics: Adolescent; Adult; Aged; Aminoquinolines; Anti-Infective Agents; Condylomata Acuminata; Consumer Product Safety; Demography; Female; Follow-Up Studies; Health Personnel; Humans; Imiquimod; Male; Middle Aged; Recurrence; Self Administration; Surveys and Questionnaires; Treatment Outcome; Vaginal Creams, Foams, and Jellies

2001

Other Studies

41 other study(ies) available for imiquimod and Recrudescence

ArticleYear
Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8
    Theranostics, 2020, Volume: 10, Issue:23

    Topics: Animals; Artemisinins; CD8-Positive T-Lymphocytes; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Imiquimod; Immunologic Memory; Interleukin-15; Interleukin-17; Male; Methotrexate; Mice; Psoriasis; Recurrence; Secondary Prevention; Skin; Skin Transplantation; Transplantation Chimera

2020
Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montréal, Canada.
    Sexually transmitted diseases, 2017, Volume: 44, Issue:11

    Topics: Administration, Topical; Adult; Aminoquinolines; Canada; Condylomata Acuminata; Cryotherapy; Female; Health Knowledge, Attitudes, Practice; Human papillomavirus 6; Humans; Imiquimod; Male; Papillomavirus Infections; Prevalence; Recurrence; Retrospective Studies; Unsafe Sex; Young Adult

2017
Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men.
    PloS one, 2018, Volume: 13, Issue:8

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Retroviral Agents; Anus Diseases; Condylomata Acuminata; Electrosurgery; Genotype; HIV Infections; Homosexuality, Male; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Infrared Rays; Male; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult

2018
[Riesgo de recurrencia y de nuevas neoplasias cutáneas malignas en sujetos mexicanos con carcinoma basocelular].
    Cirugia y cirujanos, 2018, Volume: 86, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Electrocoagulation; Female; Humans; Imiquimod; Male; Margins of Excision; Middle Aged; Mohs Surgery; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Risk; Skin Neoplasms; Young Adult

2018
Successful treatment of anal and perianal condyloma acuminata with imiquimod.
    Acta dermato-venereologica, 2014, Volume: 94, Issue:1

    Topics: Adjuvants, Immunologic; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Humans; Imiquimod; Male; Recurrence; Young Adult

2014
A 4-year-old girl who presents with repeated episodes of vaginal bleeding found to have anogenital warts.
    The Journal of emergency medicine, 2013, Volume: 45, Issue:5

    Topics: Aminoquinolines; Child Abuse, Sexual; Child, Preschool; Condylomata Acuminata; Diagnosis, Differential; Female; Hemorrhage; Humans; Imiquimod; Recurrence; Vaginal Diseases

2013
Recurrent vulvovaginal candidiasis: successful suppression with imiquimod.
    The Journal of dermatology, 2013, Volume: 40, Issue:10

    Topics: Adult; Aminoquinolines; Antineoplastic Agents; Candidiasis, Vulvovaginal; Female; Humans; Imiquimod; Papillomavirus Infections; Recurrence

2013
Imiquimod 5%: a successful treatment for pseudolymphoma.
    Acta dermato-venereologica, 2014, Volume: 94, Issue:4

    Topics: Administration, Topical; Aminoquinolines; Humans; Imiquimod; Immunologic Factors; Male; Middle Aged; Pseudolymphoma; Recurrence; Skin Diseases; Treatment Outcome

2014
Resolution of recalcitrant pyogenic granuloma with laser, corticosteroid, and timolol therapy.
    Dermatology online journal, 2014, Mar-17, Volume: 20, Issue:3

    Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Aminoquinolines; Anti-Bacterial Agents; Biopsy; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Therapy, Combination; Granuloma, Pyogenic; Humans; Imiquimod; Laser Therapy; Lasers, Dye; Lasers, Solid-State; Male; Recurrence; Scalp Dermatoses; Timolol; Triamcinolone Acetonide

2014
Anal condyloma treatment and recurrence in HIV-negative men who have sex with men.
    Diseases of the colon and rectum, 2014, Volume: 57, Issue:6

    Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Anus Diseases; Chemotherapy, Adjuvant; Condylomata Acuminata; Disease-Free Survival; Electrocoagulation; HIV Seronegativity; Homosexuality, Male; Humans; Imiquimod; Lasers, Gas; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Young Adult

2014
Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study. Does gender have a role?
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2014, Volume: 149, Issue:2

    Topics: Adult; Aged; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cohort Studies; Cryotherapy; Curettage; Diclofenac; Female; Humans; Hyaluronic Acid; Imiquimod; Italy; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Prospective Studies; Protective Clothing; Recurrence; Remission Induction; Sex Factors; Sunscreening Agents

2014
Induction of vitiligo after imiquimod treatment of condylomata acuminata.
    BMC infectious diseases, 2014, Jun-13, Volume: 14

    Topics: Administration, Topical; Adult; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Male; Recurrence; Vitiligo

2014
Plantar keloids: diagnostic and therapeutic issues in six patients.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:7

    Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Biopsy; Colchicine; Dermatologic Surgical Procedures; Drug Administration Routes; Female; Follow-Up Studies; Foot Dermatoses; Foot Orthoses; Glucocorticoids; Gout Suppressants; Humans; Imiquimod; Keloid; Keratolytic Agents; Magnetic Resonance Imaging; Male; Recurrence; Retrospective Studies; Treatment Outcome; Triamcinolone

2015
Treating recalcitrant verruca vulgaris in a pediatric patient with H2 blocker: An easy alternative approach.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2016, Volume: 115, Issue:5

    Topics: Aminoquinolines; Child; Cryotherapy; Female; Histamine H2 Antagonists; Humans; Imiquimod; Ranitidine; Recurrence; Warts

2016
Treatment of cutaneous tumors with topical 5% imiquimod cream.
    Clinics (Sao Paulo, Brazil), 2009, Volume: 64, Issue:10

    Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Brazil; Child; Female; Humans; Imiquimod; Male; Middle Aged; Recurrence; Retrospective Studies; Skin Neoplasms; Young Adult

2009
Successful treatment of recurrent and refractory cervical condylomata acuminata with topical 5% imiquimod cream in five patients.
    International journal of STD & AIDS, 2010, Volume: 21, Issue:7

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Cervix Uteri; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Recurrence

2010
The epidemiology and treatment of anogenital warts in Singapore: a retrospective evaluation.
    Annals of the Academy of Medicine, Singapore, 2002, Volume: 31, Issue:4

    Topics: Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Cost-Benefit Analysis; Cryosurgery; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Keratolytic Agents; Male; Middle Aged; Outcome Assessment, Health Care; Podophyllin; Recurrence; Retrospective Studies; Singapore

2002
Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids.
    Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4 Suppl

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Ear, External; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Keloid; Male; Middle Aged; Pilot Projects; Postoperative Care; Recurrence; Time Factors

2002
[Recurrent Bowen's disease of the nail: treatment by topical imiquimod (Aldara)].
    Annales de dermatologie et de venereologie, 2003, Volume: 130, Issue:2 Pt 1

    Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Bowen's Disease; Female; Humans; Imiquimod; Nail Diseases; Recurrence; Skin Neoplasms; Treatment Outcome

2003
Extensive and recalcitrant verrucae vulgares of the great toe treated with imiquimod 5% cream.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2003, Volume: 17, Issue:3

    Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Foot Dermatoses; Humans; Imiquimod; Male; Recurrence; Toes; Warts

2003
Imiquimod: potential risk of an immunostimulant.
    The Australasian journal of dermatology, 2004, Volume: 45, Issue:2

    Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Drug Antagonism; Female; Humans; Imiquimod; Immunosuppressive Agents; Papillomaviridae; Papillomavirus Infections; Recurrence; Skin Diseases; Spondylitis; Uterine Cervical Dysplasia; Vulvar Diseases; Warts

2004
Closing the feedback loop: an audit of the use of imiquimod for the treatment of genital warts.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2004, Volume: 18, Issue:3

    Topics: Aminoquinolines; Biopsy, Needle; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Feedback; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Immunohistochemistry; Incidence; Interferon Inducers; Male; Medical Audit; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Treatment Outcome; United Kingdom

2004
Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Aug-01, Volume: 10, Issue:15

    Topics: Adjuvants, Immunologic; Aminoquinolines; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Line, Tumor; Cell Survival; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Immunoblotting; Immunohistochemistry; Interferon-alpha; Membrane Glycoproteins; Multigene Family; Oligonucleotide Array Sequence Analysis; Receptors, Cell Surface; Receptors, Opioid; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptor 7; Toll-Like Receptors; Treatment Outcome; Up-Regulation

2004
Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:11 Pt 1

    Topics: Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Ear Diseases; Ear, External; Female; Humans; Imiquimod; Keloid; Male; Pilot Projects; Recurrence; Treatment Outcome

2005
Recurrent pyogenic granuloma treated with topical imiquimod.
    Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:5 Suppl

    Topics: Administration, Topical; Aminoquinolines; Angiogenesis Inhibitors; Fingers; Granuloma, Pyogenic; Humans; Imiquimod; Male; Middle Aged; Recurrence; Skin Diseases; Treatment Outcome

2006
Topical imiquimod for recurrent acyclovir-resistant HSV infection.
    The American journal of medicine, 2006, Volume: 119, Issue:5

    Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Drug Resistance, Viral; Herpes Simplex; Humans; Imiquimod; Male; Recurrence; Simplexvirus; Treatment Outcome

2006
Successful treatment of a therapy-resistant pyogenic granuloma with topical imiquimod 5% cream.
    The Journal of dermatological treatment, 2006, Volume: 17, Issue:2

    Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Fingers; Granuloma, Pyogenic; Humans; Imiquimod; Male; Middle Aged; Recurrence; Skin Diseases

2006
[Often they heal spontaneously and the treatments are not always harmless: concerning warts waiting and seeing is a legitimate therapy].
    MMW Fortschritte der Medizin, 2006, Jun-29, Volume: 148, Issue:26

    Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Child; Cryotherapy; Diagnosis, Differential; Female; Humans; Imiquimod; Immunotherapy; Keratolytic Agents; Laser Therapy; Male; Recurrence; Risk Factors; Time Factors; Warts

2006
Combination therapy of a large, recurrent keloid.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Cicatrix, Hypertrophic; Combined Modality Therapy; Graft Survival; Humans; Imiquimod; Keloid; Male; Neck; Occlusive Dressings; Recurrence; Skin Transplantation

2007
Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs.
    The Journal of infectious diseases, 1993, Volume: 167, Issue:3

    Topics: Acute Disease; Aminoquinolines; Analysis of Variance; Animals; Antibodies, Viral; Drug Synergism; Female; Guinea Pigs; Herpes Simplex; Imiquimod; Interferon Inducers; Random Allocation; Recurrence; Simplexvirus; Vagina; Viral Envelope Proteins; Viral Vaccines; Virus Replication; Virus Shedding

1993
Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development.
    Antiviral research, 1993, Volume: 20, Issue:1

    Topics: Acute Disease; Acyclovir; Aminoquinolines; Animals; Drug Synergism; Drug Therapy, Combination; Female; Ganglia, Spinal; Guinea Pigs; Herpes Genitalis; Imiquimod; Interferon Inducers; Recurrence; Spinal Cord; Vagina; Virus Shedding

1993
Imiquimod in clinical practice.
    The Australasian journal of dermatology, 1998, Volume: 39 Suppl 1

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imiquimod; Interferon Inducers; Interferon-alpha; Male; Pharmaceutical Vehicles; Randomized Controlled Trials as Topic; Recurrence; Remission Induction

1998
Recurrent urogenital herpes simplex--successful treatment with imiquimod?
    Sexually transmitted infections, 1999, Volume: 75, Issue:2

    Topics: Adult; Aminoquinolines; Female; Herpes Genitalis; Humans; Imiquimod; Interferon Inducers; Recurrence

1999
Imiquimod therapy for molluscum contagiosum.
    Journal of cutaneous medicine and surgery, 2000, Volume: 4, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Age Factors; AIDS-Related Opportunistic Infections; Aminoquinolines; Child; Drug Evaluation; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Male; Molluscum Contagiosum; Ointments; Recurrence; Sex Factors; Time Factors

2000
[Proven and promising for the future].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:1

    Topics: Aminoquinolines; Anus Diseases; Clinical Trials as Topic; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Ointments; Recurrence; Time Factors

2001
Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
    The British journal of dermatology, 2001, Volume: 144, Issue:5

    Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Recurrence; Scalp Dermatoses; Skin Neoplasms

2001
Imiquimod 5% cream in the treatment of anogenital warts in female patients.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2002, Volume: 77, Issue:3

    Topics: Adult; Aminoquinolines; Condylomata Acuminata; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Ointments; Recurrence; Treatment Outcome; Vaginal Creams, Foams, and Jellies

2002
Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
    International journal of dermatology, 2002, Volume: 41 Suppl 1

    Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Follow-Up Studies; Humans; Imiquimod; Immunity, Innate; Keloid; Molluscum Contagiosum; Molluscum contagiosum virus; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Recurrence; Warts

2002
Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs.
    Antiviral research, 1991, Volume: 15, Issue:4

    Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antiviral Agents; Female; Guinea Pigs; Herpes Genitalis; Imiquimod; Interferon Type I; Interleukin-2; Recurrence; Simplexvirus; Ultraviolet Rays; Virus Activation

1991
Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection.
    Antiviral research, 1988, Dec-01, Volume: 10, Issue:4-5

    Topics: Administration, Intravaginal; Aminoquinolines; Animals; Antibodies, Viral; Antibody-Dependent Cell Cytotoxicity; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Herpes Genitalis; Imiquimod; Immunity, Cellular; Interferons; Interleukin-2; Lymphocyte Activation; Neutrophils; Random Allocation; Recurrence; Simplexvirus; Vagina; Virus Replication

1988
Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:9

    Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antibody Formation; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Herpes Simplex; Imiquimod; Interferons; Nervous System Diseases; Rabbits; Recurrence; Time Factors

1989